Skip to main content

Table 5 New Comparison between CRRT-treated and other-RRT-treated patients without CRRT indications

From: Renal replacement therapy in acute kidney injury from a Chinese cross-sectional study: patient, clinical, socioeconomic and health service predictors of treatment

 

CRRT-treated (n = 119)

Other-RRT-treated (n = 162)

P

Age, years

57.3 ± 18.6

54.6 ± 16.6

0.199

Male sex

68 (57.1%)

87 (53.7%)

0.567

AKI stage at peak

  

0.835

 Stage 1

12 (10.1%)

13 (8.0%)

 

 Stage 2

8 (6.7%)

11 (6.8%)

 

 Stage 3

99 (83.2%)

138 (85.2%)

 

Severe comorbidities

11 (9.2%)

12 (7.4%)

0.579

Cost, US Dollarsa

7944 (4248,16055)

5100 (2948,9396)

<0.001

In hospital mortalityb

12 (10.6%)

7 (4.4%)

0.047

Treatment withdrawalc

23 (20.4%)

8 (5.0%)

<0.001

Renal-referral

80 (67.2%)

137 (84.6%)

0.001

Admission dept.

  

<0.001

 ICU

60 (50.4%)

11 (6.8%)

 

 Renal

22 (18.5%)

88 (54.3%)

 

 Surgical

6 (5.0%)

27 (16.7%)

 

 Other

31 (26.1%)

36 (22.2%)

 
  1. Abbreviations: CRRT continuous renal replacement therapy, RRT renal replacement therapy, AKI acute kidney disease, ICU intensive care unit
  2. aMissing value 36, bMissing value 9, cMissing value 9